| Methods |
Outcome assessor blinded, ITT |
| Participants |
Patients with culture or smear positive for anogenital gonorrhoea or confirmed recent exposure to gonorrhoea |
| Interventions |
IM ceftriaxone 1 x 125 mg versus IM spectinomycin 1 x 2 g |
| Outcomes |
Eradication, adverse effects
Follow‐up: 7 days |
| Notes |
|
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Unclear risk |
Unclear |
| Blinding of participants and personnel (performance bias)
All outcomes |
High risk |
No |
| Blinding of outcome assessment (detection bias)
All outcomes |
Low risk |
Yes |
| Incomplete outcome data (attrition bias)
All outcomes |
Low risk |
ITT |
| Selective reporting (reporting bias) |
Low risk |
No evidence |
| Other bias |
Low risk |
No evidence |
